Foghorn Therapeutics (FHTX) Accumulated Depreciation & Amortization (2020 - 2025)
Historic Accumulated Depreciation & Amortization for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $900000.0.
- Foghorn Therapeutics' Accumulated Depreciation & Amortization rose 2857.14% to $900000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $900000.0, marking a year-over-year increase of 2857.14%. This contributed to the annual value of $3.1 million for FY2024, which is 1085.71% down from last year.
- Per Foghorn Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $900000.0 for Q3 2025, which was up 2857.14% from $900000.0 recorded in Q2 2025.
- Foghorn Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $3.5 million for Q4 2023, and its period low was $700000.0 during Q3 2024.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $835000.0 (2024), whereas its average is $1.3 million.
- As far as peak fluctuations go, Foghorn Therapeutics' Accumulated Depreciation & Amortization soared by 30000.0% in 2021, and later tumbled by 2222.22% in 2024.
- Over the past 5 years, Foghorn Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $3.2 million in 2021, then increased by 2.91% to $3.3 million in 2022, then grew by 5.39% to $3.5 million in 2023, then decreased by 10.86% to $3.1 million in 2024, then crashed by 71.15% to $900000.0 in 2025.
- Its last three reported values are $900000.0 in Q3 2025, $900000.0 for Q2 2025, and $827000.0 during Q1 2025.